GlaxoSmithKline Consumer Healthcare Q1 2013 Financial Results May 01 2013

Press Release
Gurgaon, NCR India, May 01, 2013

GlaxoSmithKline Consumer Healthcare Ltd records high growth for Quarter 1 ended March 31, 2013

  • Sales up by 16% and Profits up by 19%


GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the first quarter ended March 31, 2013. Net sales at Rs. 940 crores recorded an impressive growth of 16 % over the same period in 2012 with PBT at Rs. 228 crores growing by 16 % and PAT at Rs. 156 crores growing by 19 %.

Commenting on the results, Mr. Zubair Ahmed, MD, GSKCH said, “GSKCH has been on a high growth path and has been recording a steady double digit performance. The current quarter results have yet again been in line with our expectations. Despite slowing economic conditions, the company continues to deliver superior results owing to our focus on innovation, distribution expansion and cost control. In this quarter, Megabrand Horlicks leveraged our strong nutrition science to launch Horlicks Pro Mind, a product focused on enhancing cognition in children.”

About GlaxoSmithKline Consumer Healthcare Ltd.

GSKCH is an associate of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 3500 people.

GSKCH has a strong marketing and distribution network in India comprising over 600 Distributors and direct coverage of over 750,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 125 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent Brands such as Eno, Crocin and Iodex as well as products from the global portfolio like Sensodyne, Parodontax and Breathe Right.

Media Contacts ______________________________________________________

Sakshi Mathur
Genesis Burson Marsteller 9999007585

Kuheli Ray
Genesis Burson Marsteller 9999783541